As COVID-19 Emergencies Ease, Some Progress on Telehealth Rules

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

BOSTON, MA (Feb. 15, 2023) — As public health emergency declarations related to the COVID-19 pandemic come to an end, a new study from Pioneer Institute, Cicero Institute, and Reason Foundation rates every state’s telehealth laws. The report finds Arizona and Delaware rate best across four key telehealth policy areas, while highlighting some progress in New England.

Legislation in Vermont creates a clear path to allow out-of-state providers to see Vermont patients, although some barriers to access remain; in New Hampshire, new legislation gives a green light to providers to start a telehealth visit by any mode that works for them and their patients. While Massachusetts scores a “green” rating on three of the measures, the state continues to bar access to telehealth services across state lines.

With the three-year COVID-19 pandemic largely under control, the Biden administration recently announced plans to end the COVID-19 national public health emergency on May 11. Most states have already ended their public health emergency declarations, so the temporary orders and waivers that allowed millions of patients to access telehealth services during the pandemic need to be turned into permanent laws, or patients risk losing access to healthcare options and providers may lose significant incentives to innovate, a new report warns.

The policy brief rates all 50 states in four critical areas of telehealth policy and details what each state needs to do to improve.

Arizona and Delaware stand out as the only two states rated green for good in all four key telehealth law categories related to enabling patients to access high-quality telehealth care and giving healthcare providers the flexibility to provide a variety of services now and in the future. In contrast, three states—New Jersey, South Carolina, and Virginia—fail to score green in any of the four categories the report deems critical to today’s telehealth services and future innovation.

The report grades every state’s telehealth laws in four areas crucial to patients, quality of care, and creating a regulatory environment that doesn’t stifle future healthcare improvements. It recommends that states:

  • Should define telehealth in broad terms that do not favor one type of telehealth model, giving current patients options and leaving room for future innovations.
  • Allow modal neutrality so services can be provided via audio, video, text, email, and other modes of communication.
  • Allow patients to access telehealth services, doctors, and providers across state lines.
  • Allow doctors, nurse practitioners, and others to provide all the medical services they’re trained to provide.

“A surprising number of states have only made minor tweaks to their telehealth laws,” said Josh Archambault, coauthor of the policy brief and senior fellow at Pioneer Institute and the Cicero Institute. “Lawmakers must refocus their efforts to ensure their states have clear laws and guidelines in place so that patients and providers can benefit from today’s telehealth services and future innovations.”

“During the COVID-19 pandemic, patients discovered and utilized a variety of telehealth options that offered flexible, affordable, and high-quality care, and those options shouldn’t be taken away,” added Vittorio Nastasi, coauthor and a policy analyst at Reason Foundation. “States need to improve their laws so patients have as many quality care options as possible and the future healthcare system can become more patient-centric.”

The full report, State Policy Agenda for Telehealth Innovation, also outlines how each state can modernize and upgrade its telehealth laws without stifling future advancements.

Contact

Josh Archambault at (617) 645-7679 or jarchambault@pioneerinstitute.org

Get Updates On Our Healthcare Research and Events!

Related Posts:

COVID-19 Vaccine: The End of the Epidemic is Within Reach

/
Join Host Joe Selvaggi and Virologist and Investor Dr. Peter Kolchinsky as they discuss the rapid development, efficacy, and rollout of the newly approved COVID-19 vaccines.

Voting for Health: Party Opinions, Election Results & the Healthcare Policy Implications of Election 2020

/
Join Host Joe Selvaggi as he discusses with Harvard Professor Bob Blendon his New England Journal of Medicine Special Report, "Implications of the 2020 Election for U.S. Health Policy," which covers broad differences in both party’s view of the role of government in health care and what the election results will mean for Americans.

Hockey Sidelined Again

/
After months on the sidelines, youth hockey players across the state eagerly laced up their skates in August. Under current youth and amateur sports guidelines, locker rooms operate at 50 percent capacity, only one spectator should attend per player, and players wear masks on the bench. Unlike in MIAA high school sports, players do not wear facemasks while they play, except during faceoffs. 

Survey: Consumers Want Healthcare Price Information, But Few Realize It’s Available

Great strides have been made to increase healthcare price transparency through online cost estimator tools and a state law that requires providers to give out price information. Yet despite the eagerness of consumers to access prices and out-of-pocket costs, many are unaware that such information is available and don’t know how to access it, according to survey results published by Pioneer Institute.

Staving Off Disaster: Lessons from Covid Applied to the Epic Battle Against Drug Resistant Microbes

/
Join Hubwonk host Joe Selvaggi and Pioneer Institute’s Bill Smith as they discuss with inspirational public health advocate Gunnar Esiason the findings of his latest white paper, "Antimicrobial Resistance: Learning From the current health crisis to inform another."  The episode looks at the challenges to global health presented by evolving drug resistant diseases and how the lessons learned from COVID-19 could potentially save millions of lives.

Study: Growth of Antibiotic-Resistant Infections Could Have Massive Human, Financial Costs

The world was blindsided by COVID-19, but a new Pioneer Institute study finds that even as we continue to wrestle with the pandemic, another threat looms that scientists have long known about but the nation has thus far failed to address: the growth of antibiotic-resistant infections. “Market dysfunction and perverse Medicare reimbursement rates have led to a growth in infections that resist antibiotics,” said Gunnar Esiason, author of “Antimicrobial Resistance: Learning from the current global health crisis to prevent another one.”  If we don’t solve this problem, the human and economic costs are likely to be astronomical.”

Getting Nursing Home Care Right

Pioneer Institute has long recognized that seniors deserve the best of care and that innovative policy solutions are necessary to ensure that this population enjoys a high quality of life in their later years. In the 1990s, early 2000s and most recently in 2017, the Institute dedicated Better Government Competition topics to policy issues related to aging in America. Our goal each time was to find solutions and to take advantage of new innovations that would improve the quality of life and care for the elderly.

Drug Rebates: How Pharmacy Benefit Managers Manipulate Price & Limit Choice

/
Join host Joe Selvaggi and his guest Dr. Bill Smith as they discuss the complex incentive structure between drug manufacturers, health plans, and pharmacy benefit managers. In this episode, they focus on how drug rebates work and how a system intended to optimize value may actually deliver higher costs and fewer choices. Joe and Bill also use this framework to speculate on the price of a COVID-19 vaccine, and who will likely pay for it.

Confronting COVID Constraints: How Certificate of Need laws stifle innovation, increase costs, and reduce quality in healthcare

/
Join Joe Selvaggi and co-host Josh Archambault, Pioneer Institute's Senior Fellow in Healthcare, as they talk with Institute for Justice’s Jaimie Cavanaugh about the effects of Certificate of Need laws on the healthcare system.

Study: Growing Drug Rebates Hurt Both Consumers and Healthcare System

Ever-larger rebates are distorting the market for branded drugs and producing outcomes that often benefit neither consumers nor the healthcare system, according to a new study published by Pioneer Institute.